Corcept Therapeutics Inc (NASDAQ:CORT) has 377 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 12,062,212 | 14,382 | 0.12% | $419,764,959.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 9,494,822 | -42,249 | -0.44% | $330,419,806.00 |
| INGALLS & SNYDER LLC | 31 Dec, 2025 | 7,195,060 | -502,924 | -6.53% | $250,388.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 5,758,528 | -330,819 | -5.43% | $200,396,774.00 |
| Parallel Advisors, LLC | 31 Dec, 2025 | 3,879,141 | 7,689 | 0.20% | $134,994,107.00 |
| State Street Corp | 31 Dec, 2025 | 2,986,056 | 15,656 | 0.53% | $103,914,749.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 2,668,918 | 734,646 | 37.98% | $92,891,503.00 |
| FMR LLC | 31 Dec, 2025 | 2,414,640 | 212,702 | 9.66% | $84,029,460.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 1,620,333 | -272,115 | -14.38% | $56,576,847.00 |
| Morgan Stanley | 31 Dec, 2025 | 1,592,059 | 405,081 | 34.13% | $55,403,726.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 1,062,101 | -8,180 | -0.76% | $36,961,115.00 |
| TD ASSET MANAGEMENT INC | 31 Dec, 2025 | 994,844 | 38,708 | 4.05% | $34,620,571.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 887,861 | -619,348 | -41.09% | $30,897,556.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 863,052 | 751,465 | 673.43% | $30,034,209.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 861,952 | 472,866 | 121.53% | $29,995,930.00 |
| Jpmorgan Chase & Co | 31 Dec, 2025 | 834,449 | -865,279 | -50.91% | $29,038,827.00 |
| Invesco Ltd. | 31 Dec, 2025 | 816,996 | 84,413 | 11.52% | $28,431,460.00 |
| Epoch Investment Partners, Inc. | 31 Dec, 2025 | 816,652 | -30,452 | -3.59% | $28,419,490.00 |
| Cerity Partners LLC | 31 Dec, 2025 | 755,295 | -3,131 | -0.41% | $26,284,265.00 |
| NORGES BANK | 31 Dec, 2025 | 695,766 | 695,766 | 0.00% | $24,212,657.00 |